A History of Steris

• Introduction
• Chapter 1 The Genesis of Steris: Early Years and Founding Principles
• Chapter 2 Forging a Path: Initial Products and Market Entry
• Chapter 3 Navigating Early Challenges and Triumphs
• Chapter 4 Expansion and Diversification: Broadening the Portfolio
• Chapter 5 Innovation at its Core: Key Technological Advancements
• Chapter 6 Steris Goes Public: The Journey to the Stock Exchange
• Chapter 7 Strategic Acquisitions: Growing Through Mergers
• Chapter 8 Global Reach: Expanding International Operations
• Chapter 9 Defining Moments: Pivotal Decisions and Their Impact
• Chapter 10 Leadership Through the Decades: Key Figures and Their Vision
• Chapter 11 Adapting to Change: Market Shifts and Industry Evolution
• Chapter 12 The Sterilization Revolution: Impact on Healthcare
• Chapter 13 Quality and Compliance: Upholding Standards
• Chapter 14 Employee Culture: Building a Workforce
• Chapter 15 Community and Corporate Responsibility
• Chapter 16 Research and Development: Fueling Future Growth
• Chapter 17 The Digital Transformation: Embracing New Technologies
• Chapter 18 Facing Economic Headwinds: Resilience and Strategy
• Chapter 19 Major Product Launches and Their Success
• Chapter 20 Competitors and Collaborators: Shaping the Landscape
• Chapter 21 Milestones and Anniversaries: Celebrating Achievements
• Chapter 22 The Path to the S&P 500: A Company's Ascent
• Chapter 23 Steris Today: A Global Leader
• Chapter 24 Future Horizons: Sustaining Growth and Innovation
• Chapter 25 The Enduring Legacy of Steris

In the intricate and ever-evolving landscape of global healthcare and life sciences, certain companies stand as pillars of innovation, safety, and progress. Among these, STERIS plc has carved a remarkable trajectory, transforming from a visionary startup into a global leader in infection prevention and sterilization products and services. This book, "A History of STERIS: The Story of an S&P 500 Company," chronicles that extraordinary journey, offering an in-depth look at the decisions, challenges, and triumphs that have defined its nearly four-decade existence.

Founded in 1985 in Mentor, Ohio, as "Innovative Medical Technologies," STERIS began with a singular focus: revolutionizing the reprocessing of delicate endoscopes, instruments increasingly vital to minimally invasive surgical procedures. From this focused beginning, the company embarked on a path of relentless innovation, strategic expansion, and unwavering commitment to patient safety and product integrity. Its evolution mirrors the advancements in modern medicine itself, as STERIS consistently developed solutions to meet the growing demands for sterile environments in hospitals, pharmaceutical manufacturing, and medical device industries worldwide.

This narrative delves into the critical moments that shaped STERIS, from its initial product launches and market entry to its strategic acquisitions that broadened its portfolio and global reach. We will explore the technological breakthroughs that defined its offerings, the pivotal decision to go public, and the intricate process of expanding its international operations. The book examines how STERIS adapted to significant market shifts and industry evolutions, always maintaining its core focus on quality, compliance, and fostering a robust employee culture.

Ultimately, this book tells the story of how STERIS ascended to become a constituent of the prestigious S&P 500 Index—a testament to its sustained growth, market influence, and enduring value in the medical devices industry. It is a journey marked by resilience in the face of economic headwinds, a dedication to research and development that fuels future growth, and a continuous embrace of digital transformation. By exploring the company's past and present, we gain insight into the strategies that have cemented STERIS's position as a vital partner in creating a healthier and safer world.

"A History of STERIS" offers valuable insights for a diverse readership. Business leaders and aspiring entrepreneurs will find lessons in strategic growth, market adaptation, and the navigation of complex regulatory landscapes. Professionals in the healthcare and life sciences sectors will gain a deeper understanding of the evolution of infection prevention and sterilization technologies. Investors will discover the intricate factors that contribute to the sustained success of an S&P 500 company, while anyone interested in the impact of innovation on global well-being will appreciate the profound influence STERIS has had on healthcare standards.

The story of STERIS, a company synonymous with infection prevention and sterilization, truly begins in the mid-1980s, a period marked by significant advancements in medical procedures. Minimally invasive surgeries, such as endoscopy and arthroscopy, were becoming increasingly common, offering patients quicker recovery times and reduced trauma. However, this surgical revolution presented a new challenge for healthcare providers: how to properly sterilize the delicate, heat-sensitive instruments these procedures required. Traditional sterilization methods, often involving high temperatures and harsh chemicals, would simply damage these sophisticated devices, rendering them unusable.

It was against this backdrop of evolving medical needs that Dr. Raymond Kralovic, a microbiologist then working for the Pittsburgh-based American Sterilizer Co., recognized a critical unmet need. Dr. Kralovic, an innovative researcher and a leader in the field of sterilization, envisioned a low-temperature, liquid sterilization process that could safely and effectively reprocess these fragile instruments. His idea was groundbreaking, promising to bridge the gap between advanced surgical techniques and the necessary sterilization protocols.

In 1985, driven by this vision and encountering a lack of interest from his then-employer to develop his new technique, Dr. Kralovic decided to strike out on his own. He founded Innovative Medical Technologies in Mentor, Ohio, with a clear purpose: to bring his innovative sterilization solution to the healthcare market. The company began modestly, with a small team of five employees dedicated to research and development of this liquid chemical sterilization system.

Two years later, in 1987, a pivotal moment arrived for the nascent company when businessperson Bill Sanford joined Innovative Medical Technologies. Sanford, a healthcare consultant with a keen eye for promising medical technology, recognized the immense potential of Dr. Kralovic's sterilization system. He secured $1.2 million in financing, a crucial injection of capital that would propel the company forward. With Sanford’s arrival, the company underwent a significant transformation, not only in its leadership but also in its identity. He was named the first President and CEO and, under his guidance, Innovative Medical Technologies was officially renamed STERIS Corporation.

The name change marked a fresh chapter, signaling a more focused and commercially driven enterprise. Bill Sanford's leadership instilled a strong set of founding principles that would guide STERIS throughout its growth. Among these was an unwavering commitment to putting "Customers First – Always." This principle emphasized listening to customers, understanding their needs, and providing superior products and services. This philosophy, articulated by Sanford himself, became a cornerstone of STERIS's culture, driving its strategic decisions and product development.

Another core principle was the belief in "Innovation – the best." This wasn't just about creating new products but constantly striving for the most effective and efficient solutions to complex problems in infection prevention. The very genesis of STERIS was born from an innovative idea, and that spirit continued to be central to its identity. This dedication to innovation was particularly vital in the rapidly evolving medical landscape, where new technologies and procedures constantly demanded equally advanced sterilization methods.

The early years were characterized by intense research and development, building upon Dr. Kralovic's initial concept. The goal was to refine and perfect the low-temperature, liquid sterilization process, ensuring its efficacy, safety, and practicality for widespread use in healthcare settings. This period laid the groundwork for the company's flagship product, which would soon revolutionize instrument reprocessing. The focus was on creating a system that was not only effective but also efficient, allowing healthcare professionals to quickly sterilize and reuse critical instruments multiple times a day.

The commitment to "People – the foundation" was also deeply embedded in the company's early ethos. STERIS understood that its success would be built on the talent and dedication of its employees. This meant fostering a collaborative environment where creative thinking was encouraged from everyone, recognizing that good ideas could come from any member of the team. The concept of "One Team, One Goal" emphasized a cohesive approach, where every individual contributed to the overarching mission of creating a healthier and safer world.

The establishment of STERIS Corporation in 1987, following the pioneering work of Dr. Raymond Kralovic and the strategic leadership of Bill Sanford, solidified the company's foundational principles. These principles — customer-centricity, innovation, and a strong people-focused culture — would serve as the bedrock upon which STERIS would build its future success. The company was not just created to sell a product; it was established with a mission to make a tangible difference in patient care by addressing a critical healthcare challenge. This strong sense of purpose, combined with a clear vision and dedicated leadership, set the stage for STERIS to embark on its remarkable journey to becoming a global leader in infection prevention.